Multiplex analysis of cytokines/chemokines as biomarkers that differentiate healthy contacts from tuberculosis patients in high endemic settings

被引:45
作者
Anbarasu, D. [1 ]
Raja, C. Ponnu [1 ]
Raja, Alamelu [1 ]
机构
[1] Natl Inst Res TB ICMR, Dept Immunol, Madras 600031, Tamil Nadu, India
关键词
Tuberculosis; Biomarker; Contact specific fractions; Interleukin-6; Platelet derived growth factor; ANCESTRAL MYCOBACTERIUM-TUBERCULOSIS; TUMOR-NECROSIS-FACTOR; ACTIVE TUBERCULOSIS; LATENT TUBERCULOSIS; INTERFERON-GAMMA; ANTIGENS; INFECTION; RESPONSES; VACCINATION; EFFICACY;
D O I
10.1016/j.cyto.2012.12.031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Differentiation of latent tuberculosis infection (LTBI) from active disease is one of the crucial elements in the control of tuberculosis. Earlier in Indian population which is tuberculosis endemic, we identified that 10 Mycobacterium tuberculosis secreted protein fractions, induced IFN-gamma response only in healthy contacts of TB patients (HCs) and not in tuberculosis patients (TB). These fractions were termed as "Contact Specific Fractions" ("CS" fractions) and found useful for differentiating HC from TB. Proteomic analysis revealed that "CS" fractions have 16 different proteins, of which three were novel T cell antigens. Using these "CS" fractions as stimulants, earlier IFN-gamma, TNF-alpha and IL-4 cytokine responses were studied. In the present study, in order to identify the other useful cytokine biomarkers that were differentially expressed between HC and TB, Cytokine/chemokine response to "CS" fractions were analyzed using multiplex cytokine assay system. This preliminary investigation in our tuberculosis endemic population showed six cytokine (G-CSF, IL-6, IL-7, IL-8, IL-9, and PDGF) and one receptor antagonist (IL-1Ra) that were differentially expressed between HC and TB, for the first time. Especially IL-6 and PDGF were more promising biomarkers. IL-6 measurement identified seven as HC out of 10 HC analyzed. The measurement of PDGF identified eight as TB out of 10 TB tested. Studies are underway to further validate these biomarkers for the differentiation of LTBI from active tuberculosis. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:747 / 754
页数:8
相关论文
共 52 条
[11]   Assessment of the Genetic Diversity of Mycobacterium tuberculosis esxA, esxH, and fbpB Genes among Clinical Isolates and Its Implication for the Future Immunization by New Tuberculosis Subunit Vaccines Ag85B-ESAT-6 and Ag85B-TB10.4 [J].
Davila, Jose ;
Zhang, Lixin ;
Marrs, Carl F. ;
Durmaz, Riza ;
Yang, Zhenhua .
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2010,
[12]   Immunoproteomic Identification of Human T Cell Antigens of Mycobacterium tuberculosis That Differentiate Healthy Contacts from Tuberculosis Patients [J].
Deenadayalan, Anbarasu ;
Heaslip, Darragh ;
Rajendiran, Adhilakshmi Aavudaiyappan ;
Velayudham, Banurekha Vaithilingam ;
Frederick, Sheela ;
Yang, Hong-Liang ;
Dobos, Karen ;
Belisle, John T. ;
Raja, Alamelu .
MOLECULAR & CELLULAR PROTEOMICS, 2010, 9 (03) :538-549
[13]   Immunological and proteomic analysis of preparative isoelectric focusing separated culture filtrate antigens of Mycobacterium tuberculosis [J].
Deenadayalan, Anbarasu ;
Sundaramurthi, Jagadish Chandrabose ;
Raja, Alamelu .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2010, 88 (01) :156-162
[14]  
DEVADATT.S, 1970, B WORLD HEALTH ORGAN, V42, P337
[15]   Review - Mass spectrometry and protein analysis [J].
Domon, B ;
Aebersold, R .
SCIENCE, 2006, 312 (5771) :212-217
[16]   Immunological Memory Transferred with CD4 T Cells Specific for Tuberculosis Antigens Ag85B-TB10.4: Persisting Antigen Enhances Protection [J].
Duffy, Darragh ;
Dawoodji, Amina ;
Agger, Else Marie ;
Andersen, Peter ;
Westermann, Juergen ;
Bell, Eric B. .
PLOS ONE, 2009, 4 (12)
[17]   Global burden of tuberculosis - Estimated incidence, prevalence, and mortality by country [J].
Dye, C ;
Scheele, S ;
Dolin, P ;
Pathania, V ;
Raviglione, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :677-686
[18]   Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice [J].
Eruslanov, EB ;
Lyadova, IV ;
Kondratieva, TK ;
Majorov, KB ;
Scheglov, IV ;
Orlova, MO ;
Apt, AS .
INFECTION AND IMMUNITY, 2005, 73 (03) :1744-1753
[19]   The effect of heterologous immunity upon the apparent efficacy of (eg BCG) vaccines [J].
Fine, PEM ;
Vynnycky, E .
VACCINE, 1998, 16 (20) :1923-1928
[20]   Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development [J].
Gagneux, Sebastien ;
Small, Peter M. .
LANCET INFECTIOUS DISEASES, 2007, 7 (05) :328-337